1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *sb0895* |
---|
6 | 6 | | |
---|
7 | 7 | | SENATE BILL 895 |
---|
8 | 8 | | J5 EMERGENCY BILL 3lr3017 |
---|
9 | 9 | | CF HB 382 |
---|
10 | 10 | | By: Senators Ready and Klausmeier |
---|
11 | 11 | | Introduced and read first time: February 15, 2023 |
---|
12 | 12 | | Assigned to: Rules |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Pharmacy Benefits Administration – Maryland Medical Assistance Program and 2 |
---|
19 | 19 | | Pharmacy Benefits Managers 3 |
---|
20 | 20 | | |
---|
21 | 21 | | FOR the purpose of altering the reimbursement levels for drug products that the Maryland 4 |
---|
22 | 22 | | Medical Assistance Program is required to establish and that pharmacy benefits 5 |
---|
23 | 23 | | managers that contract with a pharmacy on behalf of a managed care organization 6 |
---|
24 | 24 | | are required to reimburse the pharmacy; altering the definition of “purchaser” for 7 |
---|
25 | 25 | | purposes of certain provisions of law regulating pharmacy benefits managers to 8 |
---|
26 | 26 | | include certain insurers, nonprofit health services plans, and health maintenance 9 |
---|
27 | 27 | | organizations; and generally relating to pharmacy benefits administration. 10 |
---|
28 | 28 | | |
---|
29 | 29 | | BY repealing and reenacting, with amendments, 11 |
---|
30 | 30 | | Article – Health – General 12 |
---|
31 | 31 | | Section 15–118(b) 13 |
---|
32 | 32 | | Annotated Code of Maryland 14 |
---|
33 | 33 | | (2019 Replacement Volume and 2022 Supplement) 15 |
---|
34 | 34 | | |
---|
35 | 35 | | BY adding to 16 |
---|
36 | 36 | | Article – Health – General 17 |
---|
37 | 37 | | Section 15–118(f) 18 |
---|
38 | 38 | | Annotated Code of Maryland 19 |
---|
39 | 39 | | (2019 Replacement Volume and 2022 Supplement) 20 |
---|
40 | 40 | | |
---|
41 | 41 | | BY repealing and reenacting, with amendments, 21 |
---|
42 | 42 | | Article – Insurance 22 |
---|
43 | 43 | | Section 15–1601(s) 23 |
---|
44 | 44 | | Annotated Code of Maryland 24 |
---|
45 | 45 | | (2017 Replacement Volume and 2022 Supplement) 25 |
---|
46 | 46 | | |
---|
47 | 47 | | BY adding to 26 |
---|
48 | 48 | | Article – Insurance 27 2 SENATE BILL 895 |
---|
49 | 49 | | |
---|
50 | 50 | | |
---|
51 | 51 | | Section 15–1632 1 |
---|
52 | 52 | | Annotated Code of Maryland 2 |
---|
53 | 53 | | (2017 Replacement Volume and 2022 Supplement) 3 |
---|
54 | 54 | | |
---|
55 | 55 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 4 |
---|
56 | 56 | | That the Laws of Maryland read as follows: 5 |
---|
57 | 57 | | |
---|
58 | 58 | | Article – Health – General 6 |
---|
59 | 59 | | |
---|
60 | 60 | | 15–118. 7 |
---|
61 | 61 | | |
---|
62 | 62 | | (b) (1) [Except] SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION A ND 8 |
---|
63 | 63 | | EXCEPT as provided under paragraph [(2)] (3) of this subsection, the Program shall 9 |
---|
64 | 64 | | establish [maximum] reimbursement levels for the drug products for which there is a 10 |
---|
65 | 65 | | generic equivalent authorized under § 12–504 of the Health Occupations Article[, based on 11 |
---|
66 | 66 | | the cost of the generic product]. 12 |
---|
67 | 67 | | |
---|
68 | 68 | | (2) EXCEPT AS PROVIDED IN PARAGRAPH (4) OF THIS SUBSECTION , 13 |
---|
69 | 69 | | MINIMUM REIMBURSEMEN T LEVELS ESTABLISHED UNDER PARAGRAPH (1) OF THIS 14 |
---|
70 | 70 | | SUBSECTION SHALL BE AT LEAST EQUAL TO TH E NATIONAL AVERAGE DRUG 15 |
---|
71 | 71 | | ACQUISITION COST OF THE GENERIC PRODUCT PLUS THE 16 |
---|
72 | 72 | | FEE–FOR–SERVICE PROFESSIONAL DISPENSING FEE DETER MINED BY THE 17 |
---|
73 | 73 | | DEPARTMENT IN ACCORDA NCE WITH THE MOST RE CENT IN –STATE 18 |
---|
74 | 74 | | COST–OF–DISPENSING SURVEY . 19 |
---|
75 | 75 | | |
---|
76 | 76 | | [(2)] (3) [If] EXCEPT AS PROVIDED IN PARAGRAPH (4) OF THIS 20 |
---|
77 | 77 | | SUBSECTION, IF a prescriber directs a specific brand name drug, the reimbursement level 21 |
---|
78 | 78 | | shall be based on the [cost] NATIONAL AVERAGE DRUG ACQUISITION COST of the 22 |
---|
79 | 79 | | brand name product PLUS THE FEE–FOR–SERVICE PROFESSIONAL DISPENSING FEE 23 |
---|
80 | 80 | | DETERMINED BY THE DEPARTMENT IN ACCORDA NCE WITH THE MOST RECENT 24 |
---|
81 | 81 | | IN–STATE COST–OF–DISPENSING SURVEY . 25 |
---|
82 | 82 | | |
---|
83 | 83 | | (4) PARAGRAPHS (2) AND (3) OF THIS SUBSECTION D O NOT APPLY TO: 26 |
---|
84 | 84 | | |
---|
85 | 85 | | (I) A PHARMACY OWNED BY , OR UNDER THE SAME CO RPORATE 27 |
---|
86 | 86 | | AFFILIATION, AS A PHARMACY BENEFI TS MANAGER; OR 28 |
---|
87 | 87 | | |
---|
88 | 88 | | (II) A MAIL ORDER PHARMACY . 29 |
---|
89 | 89 | | |
---|
90 | 90 | | (F) THE PROVISIONS OF § 15–1632 OF THE INSURANCE ARTICLE APPLY TO 30 |
---|
91 | 91 | | A MANAGED CARE ORGAN IZATION THAT USES A PHARMACY BENEFITS MA NAGER TO 31 |
---|
92 | 92 | | MANAGE PRESCRIPTION DRUG COVERAGE BENEFI TS ON BEHALF OF THE MANAGED 32 |
---|
93 | 93 | | CARE ORGANIZATION . 33 |
---|
94 | 94 | | |
---|
95 | 95 | | Article – Insurance 34 SENATE BILL 895 3 |
---|
96 | 96 | | |
---|
97 | 97 | | |
---|
98 | 98 | | |
---|
99 | 99 | | 15–1601. 1 |
---|
100 | 100 | | |
---|
101 | 101 | | (s) (1) “Purchaser” means a person that offers a plan or program in the State, 2 |
---|
102 | 102 | | including the State Employee and Retiree Health and Welfare Benefits Program, AN 3 |
---|
103 | 103 | | INSURER, A NONPROFIT HEALTH S ERVICE PLAN , OR A HEALTH MAINTENA NCE 4 |
---|
104 | 104 | | ORGANIZATION , that: 5 |
---|
105 | 105 | | |
---|
106 | 106 | | [(1)] (I) provides prescription drug coverage or benefits in the State; and 6 |
---|
107 | 107 | | |
---|
108 | 108 | | [(2)] (II) enters into an agreement with a pharmacy benefits manager for 7 |
---|
109 | 109 | | the provision of pharmacy benefits management services. 8 |
---|
110 | 110 | | |
---|
111 | 111 | | (2) “PURCHASER” DOES NOT INCLUDE A N ONPROFIT HEALTH 9 |
---|
112 | 112 | | MAINTENANCE ORGANIZA TION THAT: 10 |
---|
113 | 113 | | |
---|
114 | 114 | | (I) OPERATES AS A GROUP MODEL; 11 |
---|
115 | 115 | | |
---|
116 | 116 | | (II) PROVIDES SERVICES SO LELY TO A MEMBER OR PATIENT OF 12 |
---|
117 | 117 | | THE NONPROFIT HEALTH MAINTENANCE ORGANIZA TION; AND 13 |
---|
118 | 118 | | |
---|
119 | 119 | | (III) FURNISHES SERVICES T HROUGH THE INTERNAL PHARMACY 14 |
---|
120 | 120 | | OPERATIONS OF THE N ONPROFIT HEALTH MAIN TENANCE ORGANIZATION . 15 |
---|
121 | 121 | | |
---|
122 | 122 | | 15–1632. 16 |
---|
123 | 123 | | |
---|
124 | 124 | | A PHARMACY BENEFITS MA NAGER THAT CONTRACTS WITH A PHARMACY ON 17 |
---|
125 | 125 | | BEHALF OF A MANAGED CARE ORGANIZATION , AS DEFINED IN § 15–101 OF THE 18 |
---|
126 | 126 | | HEALTH – GENERAL ARTICLE, SHALL REIMBURSE THE PHARMACY AN AMOUNT 19 |
---|
127 | 127 | | THAT IS AT LEAST EQUAL TO THE NATIONAL AVERAGE DRUG ACQUISITION COST 20 |
---|
128 | 128 | | PLUS THE FEE–FOR–SERVICE PROFESSIONAL DISPENSING FEE DETER MINED BY THE 21 |
---|
129 | 129 | | MARYLAND DEPARTMENT OF HEALTH FOR THE MARYLAND MEDICAL ASSISTANCE 22 |
---|
130 | 130 | | PROGRAM IN ACCORDANCE WITH THE MOST RECENT IN–STATE 23 |
---|
131 | 131 | | COST–OF–DISPENSING SURVEY . 24 |
---|
132 | 132 | | |
---|
133 | 133 | | SECTION 2. AND BE IT FURTHER ENACTED, That this Act is an emergency 25 |
---|
134 | 134 | | measure, is necessary for the immediate preservation of the public health or safety, has 26 |
---|
135 | 135 | | been passed by a yea and nay vote supported by three–fifths of all the members elected to 27 |
---|
136 | 136 | | each of the two Houses of the General Assembly, and shall take effect from the date it is 28 |
---|
137 | 137 | | enacted. 29 |
---|
138 | 138 | | |
---|
139 | 139 | | |
---|